← Leaderboards
David A Rudnick
Washington University
$3,126,164
Attributed
$4,335,857
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $663.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,335,857 · 4
By mechanism
R01$3,636,500 · 2
K08$546,357 · 1
R03$153,000 · 1
Top collaborators
- David H Perlmutter4 shared
Most similar at Washington University
Same institution · by research overlap
- David H Perlmutter$25,711,247
- Brian Jesse Debosch$7,536,271
- Jeffrey H Teckman$1,054,676
- Steven D Shapiro$21,129,259
- Mark E. Lowe$21,007,137
Others in their field
Top investigators on “Liver Regeneration”
- Robert H Squires · Children'S Hosp Pittsburgh/Upmc Hlth Sys$16,267,601
- Anna Mae Elizabeth Diehl · Johns Hopkins University$15,977,830
- Satdarshan Singh Monga · University Of Hawaii At Manoa$13,878,099
- William M Lee · University Of Texas Sw Med Ctr/Dallas$13,754,305
- Wolfram Goessling · Brigham And Women'S Hospital$12,131,857
- Mark A Kay · Stanford University$11,954,407
Research focus
Liver RegenerationLiver DiseasesHepaticResponsePathogenesisGenesMolecularLaboratory MouseLiverProstaglandin Endoperoxide SynthasePathway InteractionsProstaglandinsLiver DisorderSupplementationBiological Signal TransductionAlpha 1 Antitrypsin DeficiencyBaseNorthern BlottingsIn Situ HybridizationImpairmentInterleukin 6Genetically Modified AnimalsHepatectomyDisease /Disorder Model
Grant awards (17)
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease$548,069
R01 · FY2025 · DK · contact PI
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease$584,605
R01 · FY2024 · DK · contact PI
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease$623,637
R01 · FY2023 · DK · contact PI
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease$663,075
R01 · FY2022 · DK · contact PI
Hepatobiliary Pathophysiology of Liver Regeneration$233,160
R01 · FY2009 · DK · contact PI
Hepatobiliary Pathophysiology of Liver Regeneration$16,933
R01 · FY2009 · DK · contact PI
Hepatobiliary Pathophysiology of Liver Regeneration$233,160
R01 · FY2008 · DK · contact PI
Hepatobiliary Pathophysiology of Liver Regeneration$237,918
R01 · FY2007 · DK · contact PI
Hepatobiliary Pathophysiology of Liver Regeneration$245,023
R01 · FY2006 · DK · contact PI
Hepatobiliary Pathophysiology of Liver Regeneration$250,920
R01 · FY2005 · DK
LIVER REGENERATION IN PEDIATRIC LIVER DISEASE$116,284
K08 · FY2004 · DK
Liver Regeneration in Pediatric Liver Disease$76,500
R03 · FY2004 · DK
LIVER REGENERATION IN PEDIATRIC LIVER DISEASE$114,683
K08 · FY2003 · DK
Liver Regeneration in Pediatric Liver Disease$76,500
R03 · FY2003 · DK
LIVER REGENERATION IN PEDIATRIC LIVER DISEASE$111,158
K08 · FY2002 · DK
LIVER REGENERATION IN PEDIATRIC LIVER DISEASE$103,306
K08 · FY2001 · DK
LIVER REGENERATION IN PEDIATRIC LIVER DISEASE$100,926
K08 · FY2000 · DK